Structure-guided design of a GSH-activated Hsp70 targeting prodrug with enhanced tumor selectivity
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Qimeng Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Hospital of Dalian University of Technology, School of Chemistry, Dalian University of Technology, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Glutathione, HSP70 Heat-Shock Proteins. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Dalian University of Technology.
Abstract (Originalsprache)
The clinical application of heat shock protein 70 (Hsp70) inhibitors is limited due to their toxicity toward normal tissues. Targeting the Hsp70-Bim protein-protein interaction (PPI) represents a tumor-selective therapeutic strategy for CML. To further mitigate off-target effects, we rationally designed and synthesized three redox-responsive prodrugs (JL-15-B, JL-15-DNBS, and JL-15-S) by masking the critical phenolic hydroxyl group of Hsp70-Bim PPI inhibitor JL-15, aiming to restrict active drug release within the redox-abundant tumor microenvironment. Among these candidates, the GSH-responsive prodrug JL-15-DNBS exhibited efficient intracellular activation in TKI-sensitive and TKI-resistant CML cells. Upon activation, JL-15-DNBS restored Hsp70-Bim PPI-disrupting activity, triggered apoptosis, and downregulated oncogenic client proteins including AKT and eIF4E. Notably, JL-15-DNBS displayed a markedly improved tumor-to-normal-cell selectivity index compared with the parent JL-15. Biochemical assays indicated that the dual-activated prodrug JL-15-S failed to achieve the expected dual-triggered activation, showing only weak ROS-responsive properties, which highlights key lessons for subsequent dual-responsive prodrug structural optimization. Collectively, this work validates a tumor-microenvironment-activated prodrug strategy for Hsp70-Bim PPI inhibitors and identifies JL-15-DNBS as a promising lead compound with enhanced selectivity for CML therapy. Future investigations will focus on in vivo antitumor efficacy assessment, ADMET profiling, and further structural refinement to advance its translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Hospital of Dalian University of Technology, School of Chemistry, Dalian University of Technology, Dalian, Liaoning, China.
- Department of Thoracic Surgery, Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, China. Electronic address: hantianci@cancerhosp-ln-cmu.com.
- Cancer Hospital of Dalian University of Technology, School of Pharmacy, Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, China.
- School of Life Science and Technology, Dalian University of Technology, Dalian, Liaoning, China.
- Cancer Hospital of Dalian University of Technology, School of Pharmacy, Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, China. Electronic address: wangziqian@dlut.edu.cn.
- Cancer Hospital of Dalian University of Technology, School of Pharmacy, Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, China. Electronic address: zczhang@dlut.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Dalian University of Technology
Zitieren
APA
Sun, Q., Han, T., Yin, F., Song, T., Zhang, Y., Lun, H., Wang, Z., & Zhang, Z. (2026). Structure-guided design of a GSH-activated Hsp70 targeting prodrug with enhanced tumor selectivity. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110488
Vancouver
Sun Q, Han T, Yin F, Song T, Zhang Y, Lun H, et al. Structure-guided design of a GSH-activated Hsp70 targeting prodrug with enhanced tumor selectivity. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110488
BibTeX
@article{Sun2026,
author = {Sun, Qimeng and Han, Tianci and Yin, Fangkui and Song, Ting and Zhang, Yanxin and Lun, Haoxin and Wang, Ziqian and Zhang, Zhichao},
title = {Structure-guided design of a GSH-activated Hsp70 targeting prodrug with enhanced tumor selectivity},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110488}
}
EUVIMED